NEW STABILIZING AGENT FOR PHARMACEUTICAL PROTEINS

A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of > 10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of > 10 KDa. La présente invention concerne un procédé de...

Full description

Saved in:
Bibliographic Details
Main Authors RIPPNER, BRITA, AGERKVIST, IRENE, IVARSSON, ELSA, NILSSON, ULRIKA, OESTERBERG, JOSEFIN
Format Patent
LanguageEnglish
French
Published 27.10.2011
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:A method for stabilising a human blood protein or human blood plasma protein with a molecular weight of > 10 KDa by adding melezitose to a solution comprising the human blood protein or human blood plasma protein with a molecular weight of > 10 KDa. La présente invention concerne un procédé de stabilisation d'une protéine de sang humain ou d'une protéine de plasma sanguin humain ayant une masse moléculaire de > 10 KDa par addition de mélézitose à une solution comprenant la protéine de sang humain ou la protéine de plasma sanguin humain ayant une masse moléculaire de > 10 KDa.
Bibliography:Application Number: WO2011EP56326